When Shall Coronavirus Disease-19 Stop? Review of Literature

Ahmed M. El-Malky; Waad H. Al-Kathiri; Azza A. El Nouman

doi:10.3889/oamjms.2020.4844

Authors

Ahmed M. El-Malky Morbidity and Mortality Unit Supervisor, King Saud Medical City, Riyadh, Saudi Arabia; Department of Public Health and Community Medicine, Theodor Bilharz Research Institute, Academy of Scientific Research, Ministry of Scientific Resarch, Cairo, Egypt
Waad H. Al-Kathiri Department of Clinical Pharmacy Services, King Saud University Medical City, Riyadh, Saudi Arabia; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
Azza A. El Nouman Professor of Public Health, Faculty of Medicine, Cairo University, Egypt

DOI:

https://doi.org/10.3889/oamjms.2020.4844

Keywords:

Covid19, Pandemic, Medication, Economic, Psychology, Political

Abstract

In December 2019, a new coronavirus, now labeled as severe acute respiratory syndrome coronavirus 2, induced an episode of acute atypical respiratory illness started in Wuhan, Province of Hubei, China. The illness triggered by this virus was called coronavirus disease-19 (COVID-19). The infection is spread within humans and has triggered a global pandemic. The amount of death tolls continues to increase and a growing number of countries have been driven to create social barriers and lock-ups. The shortage of tailored counseling remains an issue. Epidemiological researches have shown that elderly patients are more vulnerable to serious diseases, while children tend to have milder symptoms. Here, we checked the latest understanding of this disease and found a possible explanation of the potential sequel and the expectations for the future.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Coronaviridae Positive Sense RNA Viruses Positive Sense RNA Viruses; 2011. Available from: https://www.talk.ictvonline.org/ ictv-reports/ictv_9th_report/positive-sense-rna-viruses-2011/w/ posrna_viruses/222/coronaviridae. [Last accessed on 2020 Mar 05].

Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181-92. PMid:30531947

Zhou P, Fan H, Lan T, Yang XL, Shi WF, Zhang W, et al. Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin. Nature. 2018;556(7700):255-8. PMid:29618817

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. PMid:32015507

Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses a statement of the Coronavirus Study Group. Nat Microbiol 2020; 58(9):81-9. https://doi.org/10.1101/2020.02.07.937862

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. PMid:31978945

Lu H, Stratton CW, Tang Y. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 2020;92(4):401-2. https://doi.org/10.1002/jmv.25678 PMid:32085850

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395(10223):507- 13. https://doi.org/10.1016/s0140-6736(20)30211-7 PMid:32007143

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.

Tan W, Zhao X, Ma X, Wang W, Niu P, Xu W, et al. A novel coronavirus genome identified in a cluster of pneumonia cases Wuhan, China 2019-2020. China CDC Wkly. 2020;2:61-2.

Johns Hopkins University Coronavirus COVID-19 (2019-nCoV). Available from: https://www.gisanddata. m a p s . a r c g i s . c o m / a p p s / o p s d a s h b o a r d / i n d e x . h t m l # / bda7594740fd40299423467b48e9ecf6. [Last accessed on 2020 Feb 25].

China CDC Weekly. Available from: http://www.weekly.chinacdc. cn/news/TrackingtheEpidemic.htm. [Last accessed on 2020 Feb 25].

Worldometer: Coronavirus Update (Live). Available from: https:// www.worldometers.info/coronavirus. [Last accessed on 2020 Feb 25].

Klassen, D. Updated COVID-19 Statistics. Available from: https://www.nucleuswealth.com/articles/updated-coronavirus-statistics-cases-deaths-mortality-rate. [Last accessed on 2020 Mar 03].

World Health Organization. Director-General’s Opening Remarks at the Media Briefing on COVID-19-11 March 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. [Last accessed on 2020 Mar 16].

Fan Y, Zhao K, Shi ZL, Zhou P. Bat Coronaviruses in China. Viruses. 2019;11(3):210. PMid:30832341

Cyranoski D. Did pangolins spread the China coronavirus to people? Nature. 2020 ;67(7):783-90. https://doi.org/10.1038/ d41586-020-00364-2

Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1953-66. PMid:12690092

Andersen K, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The Proximal Origin of SARS-CoV-2. Available from: http:// www.virological.org/t/the-proximal-origin-of-sars-cov-2/398. [Last accessed on 2020 Feb 25]. https://doi.org/10.1038/ s41591-020-0820-9

Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875-9. https://doi.org/10.1038/nm1267 PMid:16007097

Glowacka I, Bertram S, Muller MA, Allen P, Soilleux E, Pfefferle S, et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol. 2011;85(9):4122-34. https://doi.org/10.1128/jvi.02232-10 PMid:21325420

Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pohlmann S. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol. 2014;88(2):1293-307. https://doi.org/10.1128/jvi.02202-13 PMid:24227843

Shulla A, Heald-Sargent T, Subramanya G, Zhao J, Perlman S, Gallagher T. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J Virol. 2011;85(2):873-82. https://doi.org/10.1128/jvi.02062-10 PMid:21068237

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. Microbiology. 2020 ;56(8):359-70.

Schnirring L. More Outbreak Details Emerge as COVID-19 Cases top 70,000. Available from: http://www.cidrap.umn.edu/ news-perspective/2020/02/more-outbreak-details-emerge-covid-19-cases-top-70000. [Last accessed on 2020 Feb 25].

The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) China; 2020. Available from: http://www.weekly.chinacdc.cn/en/article/id/e53946e2- c6c4-41e9-9a9b-fea8db1a8f51. [Last accessed on 2020 Feb 25].

PM Abe Asks All of Japan Schools to Close Over Coronavirus Reuters; 2020. Available from: https://www.reuters.com/article/ us-china-health-japan-idUSKCN20L0BI. [Last accessed on 2020 Feb 27].

CNN World; Yeung J, Marsh J, Kottasová I, Vera A. March 15 Coronavirus News. Available from: https://www.cnn.com/world/ live-news/coronavirus-outbreak-2-03-15-20-intl-hnk/index.html. [Last accessed on 2020 Mar 16].

CDC Coronavirus Disease 2019 (COVID-19) Resources for K-12 Schools and Childcare Programs. Available from: https:// www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/index.html. [Last accessed on 2020 Mar 16].

Delamater PL, Street EJ, Leslie TF, Yang YT, Jacobsen KH. Complexity of the basic reproduction number (R0). Emerg Infect Dis J. 2019;25(1):1-4. https://doi.org/10.3201/eid2501.171901 PMid:30560777

Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. Int J Infect Dis. 2020;92:214-7. https://doi.org/10.1101/2020.01.23.916395 PMid:32007643

World Health Organization. Novel Coronavirus China. Available from: http://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en. [Last accessed on 2020 Feb 25].

CDC Coronavirus Disease 2019 (COVID-19). Available from: https://www.cdc.gov/coronavirus/2019-ncov/about/ transmission.html. [Last accessed on 2020 Mar 03].

Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL, Li Y, et al. The basic reproduction number (R0) of measles: A systematic review. Lancet Infect Dis. 2017;17(12):e420- 8. https://doi.org/10.1016/s1473-3099(17)30307-9 PMid:28757186

Marangi L, Mirinaviciute G, Flem E, Tomba GS, Guzzetta G, Blasio BF, et al. The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster. PLoS One. 2017;12(5):e0176845. h t t p s : / / d o i . o r g / 1 0 . 1 3 7 1 / j o u r n a l . p o n e . 0 1 7 6 8 4 5 PMid:28545047

Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104(3):246- 51. https://doi.org/10.1016/j.jhin.2020.01.022 PMid:32035997

van Doremalen N, Bushmaker T, Karesh WB, Munster VJ. Stability of Middle East respiratory syndrome coronavirus in milk. Emerg Infect Dis. 2014;20(7):1263-4. https://doi.org/10.3201/eid2007.140500 PMid:24960335

Warnes SL, Little ZR, Keevil CW. Human coronavirus 229E remains infectious on common touch surface materials. mBio. 2015;6(6):e01697-15. https://doi.org/10.1128/mbio.01697-15 PMid:26556276

Yeung J. China is Literally Laundering its Money to Contain the Coronavirus-CNN. Available from: https://www.edition.cnn. com/2020/02/17/asia/china-is-disinfecting-cash-coronavirus-intl-hnk-scli/index.html. [Last accessed on 2020 Feb 25].

Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177-9. https://doi.org/10.1056/nejmc2001737 PMid:32074444

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus infected pneumonia. N Engl J Med. 2020;382(13):1199-207. PMid:31995857

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of 2019 novel coronavirus infection in China. Respir Med. 2020;45(33):245-55.

Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill. 2020;25(5):2000062. https://doi.org/10.2807/1560-7917.es.2020.25.5.2000062 PMid:32046819

Coronavirus: Wuhan Speeds Up Testing and Treatment of Patients, East Asia News and Top Stories the Straits Times. Available from: https://www.straitstimes.com/asia/east-asia/ coronavirus-wuhan-speeds-up-testing-and-treatment-of-patients. [Last accessed on 20202 Mar 15].

Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323(14):1406-7. https://doi.org/10.1001/jama.2020.2565 PMid:32083643

Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970-1. https://doi.org/10.1056/nejmc2001468 PMid:32003551

Lipsitch M, Swerdlow DL, Finelli L. Defining the epidemiology of covid-19 studies needed. N Engl J Med. 2020;382(13):1194-6. https://doi.org/10.1056/nejmp2002125 PMid:32074416

Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. Bioinformatics. 2020;24(10):901-11. https://doi. org/10.1101/2020.01.26.919985

Cai G. Tobacco-use disparity in gene expression of ACE2, the receptor of 2019-nCov. Life Sci. 2020; 87(12):872-89. https://doi. org/10.20944/preprints202002.0051.v1

Liu S, Zhang M, Yang L, Li Y, Wang L, Huang Z, et al. Prevalence and patterns of tobacco smoking among Chinese adult men and women: Findings of the 2010 national smoking survey. J Epidemiol Community Health. 2017;71(2):154-61. https://doi.org/10.1136/jech-2016-207805 PMid:27660401

Wei M, Yuan J, Liu Y, Fu T, Yu X. Zhang ZJ. Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China. JAMA. 2020;323(13):1313-4. https://doi.org/10.1001/jama.2020.2131 PMid:32058570

Wax RS, Christian MD. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Can J Anesth. 2020;67(5):568-76. https://doi.org/10.1007/s12630-020-01591-x

Chu CM. Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings. Thorax. 2004;59(3):252-6. https://doi.org/10.1136/thorax.2003.012658 PMid:14985565

Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, Case JB, et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med. 2017;9(396):eaal3653. h t t p s : / / d o i . o r g / 1 0 . 1 1 2 6 / s c i t r a n s l m e d . a a l 3 6 5 3 PMid:28659436

Mulangu S, Dodd LE, Davey RT, Mbaya OT, Proschan M, Mukadi D, et al. A randomized, controlled trial of ebola virus disease therapeutics. N Engl J Med. 2019;381(24):2293- 303. https://doi.org/10.1056/nejmoa1910993 PMid:31774950

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269-71. https://doi.org/10.1038/s41422-020-0282-0 PMid:32020029

Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382(10):929-36. PMid:32004427

NIH (National Institute of Allergy and Infectious Diseases). NIH Clinical Trial of Remdesivir to Treat COVID-19 Begins. Available from: https://www.niaid.nih.gov/news-events/nih-clinical-trial-remdesivir-treat-covid-19-begins. [Last accessed on 2020 Feb 27].

Gilead Sciences Initiates Two Phase 3 Studies of Investigational Antiviral Remdesivir for the Treatment of COVID-19. Available from: https://www.gilead.com/news-and-press/press-room/ press-releases/2020/2/gilead-sciences-initiates-two-phase-3- studies-of-investigational-antiviral-remdesivir-for-the-treatment-of-covid-19. [Last accessed on 2020 Feb 27].

Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005;2:69. PMid:16115318

Zhou Y, Vedantham P, Lu K, Agudelo J, Carrion R, Nunneley JW, et al. Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Res. 2015;116:76- 84. https://doi.org/10.1016/j.antiviral.2015.01.011 PMid:25666761

Yamawaki H, Futagami S, Kaneko K, Agawa S, Higuchi K, Murakami M, et al. Camostat mesilate, pancrelipase, and rabeprazole combination therapy improves epigastric pain in early chronic pancreatitis and functional dyspepsia with pancreatic enzyme abnormalities. Digestion. 2019;99(4):283-92. https://doi.org/10.1159/000492813 PMid:30391941

Ramsey ML, Nuttall J, Hart PA. TACTIC Investigative Team a phase 1/2 trial to evaluate the pharmacokinetics, safety, and efficacy of NI-03 in patients with chronic pancreatitis: Study protocol for a randomized controlled trial on the assessment of camostat treatment in chronic pancreatitis (TACTIC). Trials. 2019;20(1):501. https://doi.org/10.1186/s13063-019-3606-y PMid:31412955

Hoffmann M, Kleine-Weber H, Krüger N, Müller M, Drosten C, Pöhlmann S. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv. 2020 ;13(5):273. https://doi.org/10.1101/2020.01.31.929042

Kraft CS, Hewlett AL, Koepsell S, Winkler AM, Kratochvil CJ, Larson L, et al. The use of TKM-100802 and convalescent plasma in 2 patients with ebola virus disease in the United States. Clin Infect Dis. 2015;61(4):496-502. PMid:25904375

Walker LM, Burton DR. Passive immunotherapy of viral infections: “Super-antibodies” enter the fray. Nat Rev Immunol. 2018;18(5):297-308. https://doi.org/10.1038/nri.2017.148 PMid:29379211

Wong SK, Li W, Moore MJ, Choe H, Farzan M. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J Biol Chem. 2004;279(5):3197-201. https://doi.org/10.1074/jbc.c300520200 PMid:14670965

Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450-4. https://doi.org/10.1038/nature02145 PMid:14647384

Elshabrawy HA, Coughlin MM, Baker SC, Prabhakar BS. Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing. PLoS One. 2012;7(11):e50366. h t t p s : / / d o i . o r g / 1 0 . 1 3 7 1 / j o u r n a l . p o n e . 0 0 5 0 3 6 6 PMid:23185609

Arbabi-Ghahroudi M. Camelid single-domain antibodies: Historical perspective and future outlook. Front Immunol. 2017;8:1589. https://doi.org/10.3389/fimmu.2017.01589 PMid:29209322

Moore MJ, Dorfman T, Li W, Wong SK, Li Y, Kuhn JH, et al. Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2. J Virol. 2004;78(19):10628- 35. https://doi.org/10.1128/jvi.78.19.10628-10635.2004 PMid:15367630

Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436(7047):112-6. https://doi.org/10.1038/nature03712 PMid:16001071

Reilly J, Calfee C, Christie J. Acute respiratory distress syndrome phenotypes. Semin Respir Crit Care Med. 2019;40(1):19-30. https://doi.org/10.1055/s-0039-1684049 PMid:31060085

Khan A, Benthin C, Zeno B, Albertson TE, Boyd J, Christie JD, et al. A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Crit Care. 2017;21:234. https://doi.org/10.1186/s13054-017-1823-x

Maxmen A. More than 80 clinical trials launch to test coronavirus treatments. Nature. 2020;578(7795):347-8. h t t p s : / / d o i . o r g / 1 0 . 1 0 3 8 / d 4 1 5 8 6 - 0 2 0 - 0 0 4 4 4 - 3 PMid:32071447

Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260- 3. https://doi.org/10.1101/2020.02.11.944462 PMid:32075877

Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, et al. Direct gene transfer into mouse muscle in vivo. Science. 1990;247(4949 Pt 1):1465-8. https://doi.org/10.1126/science.1690918 PMid:1690918

Sahin U, Karikó K, Türeci Ö. mRNA-based therapeutics developing a new class of drugs. Nat Rev Drug Discov. 2014;13(10):759-80. https://doi.org/10.1038/nrd4278 PMid:25233993

Sahin U, Derhovanessian E, Miller M, Kloke BP, Simon P, Löwer M, et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature. 2017;547(7662):222- 6. https://doi.org/10.3410/f.727775310.793534716 PMid:28678784

Sebastian M, Schröder A, Scheel B, Hong HS, Muth A, von Boehmer L, et al. A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/ IV non-small cell lung cancer. Cancer Immunol Immunother. 2019;68(5):799-812. https://doi.org/10.1007/s00262-019-02315-x PMid:30770959

Diken M, Kranz LM, Kreiter S, Sahin U. mRNA: A versatile molecule for cancer vaccines. Curr Issues Mol Biol. 2017;22:113-28. https://doi.org/10.21775/cimb.022.113 PMid:27801664

Safety and Immunogenicity Study of 2019-nCov Vaccine (mRNA- 1273) to Treat Novel Coronavirus Full Text View. Available from: https://www.clinicaltrials.gov/ct2/show/NCT04283461. [Last accessed on 2020 Feb 27].